Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CALIX, INC(CALX) · Entity 4385 | Director · President & CEO | February 12, 2026 | February 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CALIX, INC
Report date February 12, 2026 · Filed February 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,556 |
Reported balance
After 2026-02-14 transaction · row 1
1 source rowRow 1 · 2026-02-14 · Grant · Acquired 439 · Balance 16,556 F1: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Calix, Inc. Amended and Restated Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of August 15, 2025 through February 14, 2026. This transaction is exempt under Rule 16b-3(c). F2: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on February 13, 2026, the last trading day of the purchase period. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.68 · Expires 2035-01-31 | Direct | 217,500 |
Reported balance
After 2026-02-12 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-02-12 · Grant · Acquired 217,500 · Balance 217,500 F3: On January 31, 2025, the reporting person was granted a performance-based option to purchase 217,500 shares of common stock. On February 12, 2026, the Compensation Committee determined that the performance criteria governing 100% of the grant had been achieved. The option vests: (i) as to 25% of the shares of common stock subject to the stock option, on January 31, 2026; and (ii) as to the remaining 75% of the shares of common stock subject to the option, quarterly in equal installments over 36 months from January 31, 2026, subject to continued employment with Calix through the applicable vesting dates. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Calix, Inc. Amended and Restated Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of August 15, 2025 through February 14, 2026. This transaction is exempt under Rule 16b-3(c).
F2: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on February 13, 2026, the last trading day of the purchase period.
F3: On January 31, 2025, the reporting person was granted a performance-based option to purchase 217,500 shares of common stock. On February 12, 2026, the Compensation Committee determined that the performance criteria governing 100% of the grant had been achieved. The option vests: (i) as to 25% of the shares of common stock subject to the stock option, on January 31, 2026; and (ii) as to the remaining 75% of the shares of common stock subject to the option, quarterly in equal installments over 36 months from January 31, 2026, subject to continued employment with Calix through the applicable vesting dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 14, 2026 Filed Feb 17, 2026 16:05 UTC | CALIX, INC (CALX) · Entity 4385 | GrantCommon Stock | 439 | $45.32 | $19,896.36 |
DisclosureSEC source: 0001678385-26-000002 · wk-form4_1771362327.xml · nonDerivative · entry 1 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,556 F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Calix, Inc. Amended and Restated Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of August 15, 2025 through February 14, 2026. This transaction is exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on February 13, 2026, the last trading day of the purchase period. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 16:05 UTC | CALIX, INC (CALX) · Entity 4385 | GrantStock Option (right to buy) · Derivative | 217,500 | $0.00 Strike: $39.68 | $0.00 |
DisclosureSEC source: 0001678385-26-000002 · wk-form4_1771362327.xml · derivative · entry 2 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 217,500 Underlying: Common Stock · 217,500 shares Expires 2035-01-31 F3 · derivative.exercise_date: On January 31, 2025, the reporting person was granted a performance-based option to purchase 217,500 shares of common stock. On February 12, 2026, the Compensation Committee determined that the performance criteria governing 100% of the grant had been achieved. The option vests: (i) as to 25% of the shares of common stock subject to the stock option, on January 31, 2026; and (ii) as to the remaining 75% of the shares of common stock subject to the option, quarterly in equal installments over 36 months from January 31, 2026, subject to continued employment with Calix through the applicable vesting dates. Read SEC document |
| November 03, 2025 Filed Nov 3, 2025 19:11 UTC | CALIX, INC (CALX) · Entity 4385 | Exercise / conversionStock Option (right to buy) · Derivative | 74,000 | $0.00 Strike: $7.84 | $0.00 |
DisclosureSEC source: 0001678385-25-000013 · wk-form4_1762215093.xml · derivative · entry 7 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 74,000 shares Expires 2029-11-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 100% of the shares subject to the option were fully vested and exercisable on November 27, 2023. Read SEC document |
| November 03, 2025 Filed Nov 3, 2025 19:11 UTC | CALIX, INC (CALX) · Entity 4385 | SaleCommon Stock | 74,000 | $67.42 | $4,989,102.20 |
DisclosureSEC source: 0001678385-25-000013 · wk-form4_1762215093.xml · nonDerivative · entry 5 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,117 F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $66.245 to $69.450, inclusive. Full information on the number of shares sold at each sale price is available upon request. Read SEC document |
| November 03, 2025 Filed Nov 3, 2025 19:11 UTC | CALIX, INC (CALX) · Entity 4385 | Exercise / conversionCommon Stock | 74,000 | $7.84 | $580,160.00 |
DisclosureSEC source: 0001678385-25-000013 · wk-form4_1762215093.xml · nonDerivative · entry 4 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 90,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 30, 2025 Filed Nov 3, 2025 19:11 UTC | CALIX, INC (CALX) · Entity 4385 | Exercise / conversionStock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $7.84 | $0.00 |
DisclosureSEC source: 0001678385-25-000013 · wk-form4_1762215093.xml · derivative · entry 6 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,000 Underlying: Common Stock · 200,000 shares Expires 2029-11-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 100% of the shares subject to the option were fully vested and exercisable on November 27, 2023. Read SEC document |
| October 30, 2025 Filed Nov 3, 2025 19:11 UTC | CALIX, INC (CALX) · Entity 4385 | SaleCommon Stock | 50,000 | $67.55 | $3,377,280.00 |
DisclosureSEC source: 0001678385-25-000013 · wk-form4_1762215093.xml · nonDerivative · entry 3 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,117 F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $67.35 to $67.93, inclusive. Full information on the number of shares sold at each sale price is available upon request. Read SEC document |
| October 30, 2025 Filed Nov 3, 2025 19:11 UTC | CALIX, INC (CALX) · Entity 4385 | SaleCommon Stock | 150,000 | $64.63 | $9,694,200.00 |
DisclosureSEC source: 0001678385-25-000013 · wk-form4_1762215093.xml · nonDerivative · entry 2 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,117 F1 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $64.55 to $65.00, inclusive. Full information on the number of shares sold at each sale price is available upon request. Read SEC document |
| October 30, 2025 Filed Nov 3, 2025 19:11 UTC | CALIX, INC (CALX) · Entity 4385 | Exercise / conversionCommon Stock | 200,000 | $7.84 | $1,568,000.00 |
DisclosureSEC source: 0001678385-25-000013 · wk-form4_1762215093.xml · nonDerivative · entry 1 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 216,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2025 Filed Sep 11, 2025 18:33 UTC | CALIX, INC (CALX) · Entity 4385 | Exercise / conversionStock Option (right to buy) · Derivative | 18,010 | $0.00 Strike: $7.84 | $0.00 |
DisclosureSEC source: 0001678385-25-000011 · wk-form4_1757629976.xml · derivative · entry 9 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 274,000 Underlying: Common Stock · 18,010 shares Expires 2029-11-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 100% of the shares subject to the option were fully vested and exercisable on November 27, 2023. Read SEC document |
| September 11, 2025 Filed Sep 11, 2025 18:33 UTC | CALIX, INC (CALX) · Entity 4385 | SaleCommon Stock | 18,010 | $63.00 | $1,134,630.00 |
DisclosureSEC source: 0001678385-25-000011 · wk-form4_1757629976.xml · nonDerivative · entry 6 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,117 Read SEC document |
| September 11, 2025 Filed Sep 11, 2025 18:33 UTC | CALIX, INC (CALX) · Entity 4385 | Exercise / conversionCommon Stock | 18,010 | $7.84 | $141,198.40 |
DisclosureSEC source: 0001678385-25-000011 · wk-form4_1757629976.xml · nonDerivative · entry 5 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,127 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2025 Filed Sep 11, 2025 18:33 UTC | CALIX, INC (CALX) · Entity 4385 | Exercise / conversionStock Option (right to buy) · Derivative | 7,990 | $0.00 Strike: $7.84 | $0.00 |
DisclosureSEC source: 0001678385-25-000011 · wk-form4_1757629976.xml · derivative · entry 8 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 292,010 Underlying: Common Stock · 7,990 shares Expires 2029-11-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 100% of the shares subject to the option were fully vested and exercisable on November 27, 2023. Read SEC document |
| September 10, 2025 Filed Sep 11, 2025 18:33 UTC | CALIX, INC (CALX) · Entity 4385 | Exercise / conversionStock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $7.84 | $0.00 |
DisclosureSEC source: 0001678385-25-000011 · wk-form4_1757629976.xml · derivative · entry 7 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 150,000 shares Expires 2029-11-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 100% of the shares subject to the option were fully vested and exercisable on November 27, 2023. Read SEC document |
| September 10, 2025 Filed Sep 11, 2025 18:33 UTC | CALIX, INC (CALX) · Entity 4385 | SaleCommon Stock | 7,990 | $63.00 | $503,370.00 |
DisclosureSEC source: 0001678385-25-000011 · wk-form4_1757629976.xml · nonDerivative · entry 4 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,117 Read SEC document |
| September 10, 2025 Filed Sep 11, 2025 18:33 UTC | CALIX, INC (CALX) · Entity 4385 | Exercise / conversionCommon Stock | 7,990 | $7.84 | $62,641.60 |
DisclosureSEC source: 0001678385-25-000011 · wk-form4_1757629976.xml · nonDerivative · entry 3 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,107 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2025 Filed Sep 11, 2025 18:33 UTC | CALIX, INC (CALX) · Entity 4385 | SaleCommon Stock | 150,000 | $62.00 | $9,300,000.00 |
DisclosureSEC source: 0001678385-25-000011 · wk-form4_1757629976.xml · nonDerivative · entry 2 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,117 Read SEC document |
| September 10, 2025 Filed Sep 11, 2025 18:33 UTC | CALIX, INC (CALX) · Entity 4385 | Exercise / conversionCommon Stock | 150,000 | $7.84 | $1,176,000.00 |
DisclosureSEC source: 0001678385-25-000011 · wk-form4_1757629976.xml · nonDerivative · entry 1 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 166,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 16:08 UTC | CALIX, INC (CALX) · Entity 4385 | Exercise / conversionStock Option (right to buy) · Derivative | 24,000 | $0.00 Strike: $7.84 | $0.00 |
DisclosureSEC source: 0001678385-25-000009 · wk-form4_1757362121.xml · derivative · entry 3 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 24,000 shares Expires 2029-11-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 100% of the shares subject to the option were fully vested and exercisable on November 27, 2023. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 16:08 UTC | CALIX, INC (CALX) · Entity 4385 | SaleCommon Stock | 24,000 | $60.00 | $1,440,000.00 |
DisclosureSEC source: 0001678385-25-000009 · wk-form4_1757362121.xml · nonDerivative · entry 2 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,117 Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 16:08 UTC | CALIX, INC (CALX) · Entity 4385 | Exercise / conversionCommon Stock | 24,000 | $7.84 | $188,160.00 |
DisclosureSEC source: 0001678385-25-000009 · wk-form4_1757362121.xml · nonDerivative · entry 1 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 28, 2025 Filed Sep 2, 2025 17:05 UTC | CALIX, INC (CALX) · Entity 4385 | Exercise / conversionStock Option (right to buy) · Derivative | 126,000 | $0.00 Strike: $7.84 | $0.00 |
DisclosureSEC source: 0001406666-25-000037 · wk-form4_1756847134.xml · derivative · entry 3 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 474,000 Underlying: Common Stock · 126,000 shares Expires 2029-11-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 100% of the shares subject to the option were fully vested and exercisable on November 27, 2023. Read SEC document |
| August 28, 2025 Filed Sep 2, 2025 17:05 UTC | CALIX, INC (CALX) · Entity 4385 | SaleCommon Stock | 126,000 | $60.00 | $7,560,000.00 |
DisclosureSEC source: 0001406666-25-000037 · wk-form4_1756847134.xml · nonDerivative · entry 2 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,117 Read SEC document |
| August 28, 2025 Filed Sep 2, 2025 17:05 UTC | CALIX, INC (CALX) · Entity 4385 | Exercise / conversionCommon Stock | 126,000 | $7.84 | $987,840.00 |
DisclosureSEC source: 0001406666-25-000037 · wk-form4_1756847134.xml · nonDerivative · entry 1 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 14, 2025 Filed Aug 15, 2025 16:23 UTC | CALIX, INC (CALX) · Entity 4385 | GrantCommon Stock | 305 | $33.69 | $10,274.08 |
DisclosureSEC source: 0001678385-25-000005 · wk-form4_1755289420.xml · nonDerivative · entry 1 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,117 F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Calix, Inc. Amended and Restated Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of February 15, 2025 through August 14, 2025. This transaction is exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on February 18, 2025, the first trading day of the purchase period. Read SEC document |
| August 04, 2025 Filed Aug 5, 2025 17:03 UTC | CALIX, INC (CALX) · Entity 4385 | Exercise / conversionStock Option (right to buy) · Derivative | 74,000 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0001678385-25-000004 · wk-form4_1754427782.xml · derivative · entry 3 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 74,000 shares Expires 2029-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 100% of the shares subject to the option were fully vested and exercisable on February 14, 2023. Read SEC document |
| August 04, 2025 Filed Aug 5, 2025 17:03 UTC | CALIX, INC (CALX) · Entity 4385 | SaleCommon Stock | 74,000 | $57.00 | $4,218,000.00 |
DisclosureSEC source: 0001678385-25-000004 · wk-form4_1754427782.xml · nonDerivative · entry 2 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,812 Read SEC document |
| August 04, 2025 Filed Aug 5, 2025 17:03 UTC | CALIX, INC (CALX) · Entity 4385 | Exercise / conversionCommon Stock | 74,000 | $8.03 | $594,220.00 |
DisclosureSEC source: 0001678385-25-000004 · wk-form4_1754427782.xml · nonDerivative · entry 1 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,812 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 23, 2025 Filed Jul 24, 2025 18:42 UTC | CALIX, INC (CALX) · Entity 4385 | Exercise / conversionStock Option (right to buy) · Derivative | 16,000 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0001678385-25-000003 · wk-form4_1753396962.xml · derivative · entry 9 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,000 Underlying: Common Stock · 16,000 shares Expires 2029-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 100% of the shares subject to the option were fully vested and exercisable on February 14, 2023. Read SEC document |
| July 23, 2025 Filed Jul 24, 2025 18:42 UTC | CALIX, INC (CALX) · Entity 4385 | Exercise / conversionStock Option (right to buy) · Derivative | 92,000 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001678385-25-000003 · wk-form4_1753396962.xml · derivative · entry 8 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 92,000 shares Expires 2027-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 100% of the shares subject to the option were fully vested and exercisable on January 1, 2021. Read SEC document |
| July 23, 2025 Filed Jul 24, 2025 18:42 UTC | CALIX, INC (CALX) · Entity 4385 | SaleCommon Stock | 16,000 | $57.00 | $912,000.00 |
DisclosureSEC source: 0001678385-25-000003 · wk-form4_1753396962.xml · nonDerivative · entry 6 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,812 Read SEC document |
| July 23, 2025 Filed Jul 24, 2025 18:42 UTC | CALIX, INC (CALX) · Entity 4385 | Exercise / conversionCommon Stock | 16,000 | $8.03 | $128,480.00 |
DisclosureSEC source: 0001678385-25-000003 · wk-form4_1753396962.xml · nonDerivative · entry 5 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 31,812 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 23, 2025 Filed Jul 24, 2025 18:42 UTC | CALIX, INC (CALX) · Entity 4385 | SaleCommon Stock | 92,000 | $56.00 | $5,152,000.00 |
DisclosureSEC source: 0001678385-25-000003 · wk-form4_1753396962.xml · nonDerivative · entry 4 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,812 Read SEC document |
| July 23, 2025 Filed Jul 24, 2025 18:42 UTC | CALIX, INC (CALX) · Entity 4385 | Exercise / conversionCommon Stock | 92,000 | $5.95 | $547,400.00 |
DisclosureSEC source: 0001678385-25-000003 · wk-form4_1753396962.xml · nonDerivative · entry 3 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 107,812 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 22, 2025 Filed Jul 24, 2025 18:42 UTC | CALIX, INC (CALX) · Entity 4385 | Exercise / conversionStock Option (right to buy) · Derivative | 92,000 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001678385-25-000003 · wk-form4_1753396962.xml · derivative · entry 7 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 92,000 Underlying: Common Stock · 92,000 shares Expires 2027-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 100% of the shares subject to the option were fully vested and exercisable on January 1, 2021. Read SEC document |
| July 22, 2025 Filed Jul 24, 2025 18:42 UTC | CALIX, INC (CALX) · Entity 4385 | SaleCommon Stock | 92,000 | $55.00 | $5,060,000.00 |
DisclosureSEC source: 0001678385-25-000003 · wk-form4_1753396962.xml · nonDerivative · entry 2 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,812 Read SEC document |
| July 22, 2025 Filed Jul 24, 2025 18:42 UTC | CALIX, INC (CALX) · Entity 4385 | Exercise / conversionCommon Stock | 92,000 | $5.95 | $547,400.00 |
DisclosureSEC source: 0001678385-25-000003 · wk-form4_1753396962.xml · nonDerivative · entry 1 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 107,812 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2025 Filed Jun 3, 2025 16:25 UTC | CALIX, INC (CALX) · Entity 4385 | Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $5.95 | $0.00 |
DisclosureSEC source: 0001406666-25-000030 · wk-form4_1748982296.xml · derivative · entry 5 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 184,000 Underlying: Common Stock · 20,000 shares Expires 2027-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 100% of the shares subject to the option were fully vested and exercisable on January 1, 2021. Read SEC document |
| June 02, 2025 Filed Jun 3, 2025 16:25 UTC | CALIX, INC (CALX) · Entity 4385 | Exercise / conversionStock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $6.38 | $0.00 |
DisclosureSEC source: 0001406666-25-000030 · wk-form4_1748982296.xml · derivative · entry 4 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 80,000 shares Expires 2026-06-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 100% of the shares subject to the option were fully vested and exercisable on June 27, 2020. Read SEC document |
| June 02, 2025 Filed Jun 3, 2025 16:25 UTC | CALIX, INC (CALX) · Entity 4385 | SaleCommon Stock | 100,000 | $46.59 | $4,658,710.00 |
DisclosureSEC source: 0001406666-25-000030 · wk-form4_1748982296.xml · nonDerivative · entry 3 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,812 F1 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.025 to $47.005, inclusive. Full information on the number of shares sold at each sale price is available upon request. Read SEC document |
| June 02, 2025 Filed Jun 3, 2025 16:25 UTC | CALIX, INC (CALX) · Entity 4385 | Exercise / conversionCommon Stock | 20,000 | $5.95 | $119,000.00 |
DisclosureSEC source: 0001406666-25-000030 · wk-form4_1748982296.xml · nonDerivative · entry 2 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,812 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2025 Filed Jun 3, 2025 16:25 UTC | CALIX, INC (CALX) · Entity 4385 | Exercise / conversionCommon Stock | 80,000 | $6.38 | $510,400.00 |
DisclosureSEC source: 0001406666-25-000030 · wk-form4_1748982296.xml · nonDerivative · entry 1 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 95,812 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2025 Filed Feb 18, 2025 16:43 UTC | CALIX, INC (CALX) · Entity 4385 | GrantCommon Stock | 349 | $31.37 | $10,946.39 |
DisclosureSEC source: 0001406666-25-000007 · wk-form4_1739914999.xml · nonDerivative · entry 1 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,812 F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Calix, Inc. Amended and Restated Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of August 15, 2024 through February 14, 2025. This transaction is exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on August 15, 2024, the first trading day of the purchase period. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:17 UTC | CALIX, INC (CALX) · Entity 4385 | GrantStock Option (right to buy) · Derivative | 217,500 | $0.00 Strike: $39.68 | $0.00 |
DisclosureSEC source: 0001406666-25-000005 · wk-form4_1738703851.xml · derivative · entry 3 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 217,500 Underlying: Common Stock · 217,500 shares Expires 2035-01-31 F3 · derivative.exercise_date: The option vests: (i) as to 25% of the shares of common stock subject to the option, on January 31, 2026; and (ii) as to the remaining 75% of the shares of common stock subject to the option, quarterly in equal installments over 36 months from January 31, 2026, subject to continued employment with Calix through the applicable vesting dates. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:17 UTC | CALIX, INC (CALX) · Entity 4385 | GrantStock Option (right to buy) · Derivative | 80,325 | $0.00 Strike: $34.26 | $0.00 |
DisclosureSEC source: 0001406666-25-000005 · wk-form4_1738703851.xml · derivative · entry 2 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,325 Underlying: Common Stock · 80,325 shares Expires 2034-02-08 F2 · derivative.exercise_date: On February 8, 2024, the reporting person was granted a performance-based option to purchase 87,500 shares of common stock. On January 31, 2025, the Committee determined that the performance criteria governing 91.8% of the grant had been achieved, resulting in 80,325 shares of common stock remaining subject to the option. The option vests: (i) as to 25% of the shares of common stock subject to the option, on February 8, 2025; and (ii) as to the remaining 75% of the shares of common stock subject to the option, quarterly in equal installments over 36 months from February 8, 2025, subject to continued employment with Calix through the applicable vesting dates. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 16:17 UTC | CALIX, INC (CALX) · Entity 4385 | GrantStock Option (right to buy) · Derivative | 125,737 | $0.00 Strike: $34.26 | $0.00 |
DisclosureSEC source: 0001406666-25-000005 · wk-form4_1738703851.xml · derivative · entry 1 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,737 Underlying: Common Stock · 125,737 shares Expires 2034-02-08 F1 · derivative.exercise_date: On February 8, 2024, the reporting person was granted a performance-based stock option to purchase 262,500 shares of common stock. On January 31, 2025, the Talent and Compensation Committee (the Committee) of the Board of Directors of Calix, Inc. (Calix) determined that the performance criteria governing 47.9% of the grant had been achieved, resulting in 125,737 shares of common stock remaining subject to the option. The option vests: (i) as to 25% of the shares of common stock subject to the option, on February 8, 2025; and (ii) as to the remaining 75% of the shares of common stock subject to the option, quarterly in equal installments over 36 months from February 8, 2025, subject to continued employment with Calix through the applicable vesting dates. Read SEC document |
| August 14, 2024 Filed Aug 15, 2024 16:11 UTC | CALIX, INC (CALX) · Entity 4385 | GrantCommon Stock | 1 | $29.60 | $29.60 |
DisclosureSEC source: 0001406666-24-000037 · wk-form4_1723752709.xml · nonDerivative · entry 1 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,463 F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Calix, Inc. Amended and Restated Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of February 15, 2024 through August 14, 2024. This transaction is exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on February 15, 2024, the first trading day of the purchase period. Read SEC document |
| February 14, 2024 Filed Feb 15, 2024 15:32 UTC | CALIX, INC (CALX) · Entity 4385 | GrantCommon Stock | 777 | $29.48 | $22,904.41 |
DisclosureSEC source: 0001406666-24-000008 · wk-form4_1708029134.xml · nonDerivative · entry 1 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,462 F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Calix, Inc. Amended and Restated Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of August 15, 2023 through February 14, 2024. This transaction is exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on February 14, 2024, the last trading day of the purchase period. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 18:12 UTC | CALIX, INC (CALX) · Entity 4385 | GrantStock Option (right to buy) · Derivative | 54,500 | $0.00 Strike: $51.55 | $0.00 |
DisclosureSEC source: 0001406666-24-000006 · wk-form4_1707779557.xml · derivative · entry 2 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,500 Underlying: Common Stock · 54,500 shares Expires 2033-02-09 F3 · derivative.exercise_date: On February 9, 2023, the reporting person was awarded a performance-based nonqualified stock option grant covering 100,000 shares of common stock. On February 8, 2024, the Compensation Committee of Calix, Inc. determined that the performance criteria governing 54.5% of the grant had been achieved, resulting in a nonqualified stock option award of 54,500 shares of common stock for the reporting person. The nonqualified stock option award shall vest: (i) as to 25% of the shares of common stock subject to the stock option award, on February 8, 2024; and (ii) as to the remaining 75% of the shares of common stock subject to the stock option award, quarterly in equal installments over 36 months from February 8, 2024. Read SEC document |
| November 27, 2023 Filed Nov 28, 2023 17:14 UTC | CALIX, INC (CALX) · Entity 4385 | GrantCommon Stock · Derivative | 120,000 | $0.00 Strike: $37.80 | $0.00 |
DisclosureSEC source: 0001406666-23-000043 · wk-form4_1701209643.xml · derivative · entry 1 Weening Michael · CIK 0001678385 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock (right to buy) · 120,000 shares Expires 2033-11-27 F1 · derivative.exercise_date: 25% of the shares subject to the stock option grant will vest on November 27, 2024, with the remainder vesting quarterly thereafter in substantially equal installments over the next 36 months, subject to the reporting person's continued employment with Calix through the applicable vesting dates. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.